NO302755B1 - Morfinan-derivater - Google Patents
Morfinan-derivaterInfo
- Publication number
- NO302755B1 NO302755B1 NO933376A NO933376A NO302755B1 NO 302755 B1 NO302755 B1 NO 302755B1 NO 933376 A NO933376 A NO 933376A NO 933376 A NO933376 A NO 933376A NO 302755 B1 NO302755 B1 NO 302755B1
- Authority
- NO
- Norway
- Prior art keywords
- nch3
- morphinan derivatives
- xso2
- alkylene
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Fertilizers (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1011592 | 1992-01-23 | ||
JP29430892 | 1992-11-02 | ||
PCT/JP1993/000080 WO1993015081A1 (fr) | 1992-01-23 | 1993-01-22 | Derive de morphinane et utilisation en medicine |
Publications (3)
Publication Number | Publication Date |
---|---|
NO933376D0 NO933376D0 (no) | 1993-09-22 |
NO933376L NO933376L (no) | 1993-09-23 |
NO302755B1 true NO302755B1 (no) | 1998-04-20 |
Family
ID=26345314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO933376A NO302755B1 (no) | 1992-01-23 | 1993-09-22 | Morfinan-derivater |
Country Status (15)
Country | Link |
---|---|
US (2) | US6323212B1 (no) |
EP (2) | EP0846694A1 (no) |
JP (1) | JP2525552B2 (no) |
KR (1) | KR970011390B1 (no) |
AT (1) | ATE172201T1 (no) |
AU (2) | AU666702B2 (no) |
CA (1) | CA2105072C (no) |
DE (1) | DE69321525T2 (no) |
DK (1) | DK0577847T3 (no) |
ES (1) | ES2121988T3 (no) |
FI (1) | FI106126B (no) |
NO (1) | NO302755B1 (no) |
NZ (1) | NZ246687A (no) |
TW (1) | TW332814B (no) |
WO (1) | WO1993015081A1 (no) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2525552B2 (ja) * | 1992-01-23 | 1996-08-21 | 東レ株式会社 | モルヒナン誘導体および医薬用途 |
AU683664B2 (en) * | 1993-06-30 | 1997-11-20 | Toray Industries, Inc. | Antitussive |
EP0661283B1 (en) * | 1993-07-19 | 1998-10-21 | Toray Industries, Inc. | Brain cell protective |
NZ268969A (en) * | 1993-07-23 | 1997-06-24 | Toray Industries | Morphinan derivatives and pharmaceutical compositions |
SE9401727D0 (sv) * | 1994-05-18 | 1994-05-18 | Astra Ab | New compounds I |
DE19602964A1 (de) * | 1995-12-20 | 1997-07-31 | Nycomed Arzneimittel Gmbh | Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung |
US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
EP0829481A1 (en) * | 1996-09-16 | 1998-03-18 | Pfizer Inc. | Morphinan hydroxamic acid compounds |
EP1312361A1 (en) * | 1996-11-25 | 2003-05-21 | Toray Industries, Inc. | Antipruritic agent |
ATE377602T1 (de) | 1997-03-27 | 2007-11-15 | Toray Industries | Morphinanderivate und ihre medizinische anwendung |
EP0948965B1 (en) * | 1997-07-11 | 2004-06-02 | Toray Industries, Inc. | Stable medicinal compositions containing 4,5-epoxymorphinane derivatives |
WO1999003459A1 (en) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
US5760023A (en) * | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
AU6117298A (en) * | 1997-07-25 | 1999-02-16 | Toray Industries, Inc. | Hyponatremia remedies |
WO1999011289A1 (fr) * | 1997-09-02 | 1999-03-11 | Toray Industries, Inc. | Remedes contre la toxicomanie |
US6083944A (en) * | 1997-10-07 | 2000-07-04 | Cephalon, Inc. | Quinoline-containing α-ketoamide cysteine and serine protease inhibitors |
TW570920B (en) * | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
ES2308990T3 (es) * | 1999-08-24 | 2008-12-16 | Toray Industries, Inc. | Remedios para el dolor neuropatico y modelos animales de dolor neuropatico. |
JP2003515375A (ja) * | 1999-12-03 | 2003-05-07 | イオウリ マロヴ, | 拡散スペクトル技術による現場試験 |
WO2001074819A1 (fr) * | 2000-04-03 | 2001-10-11 | Toray Industries, Inc. | Agents analgesiques contenant des derives de n-oxyde de morphinane en tant que principe actif |
JP4453254B2 (ja) * | 2001-03-30 | 2010-04-21 | 東レ株式会社 | レストレス・レッグズ症候群治療薬 |
WO2002080918A1 (fr) * | 2001-04-02 | 2002-10-17 | Toray Industries, Inc. | Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire |
DE10161963A1 (de) * | 2001-12-17 | 2003-07-03 | Johannes Schuetz | 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung |
WO2003097608A2 (en) | 2002-05-17 | 2003-11-27 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
JP4016986B2 (ja) * | 2002-10-09 | 2007-12-05 | 東レ株式会社 | 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体 |
US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
AU2004245057B2 (en) * | 2003-06-04 | 2008-07-31 | Alkermes Pharma Ireland Limited | Polymorphic forms of naltrexone |
US8481501B2 (en) * | 2004-05-28 | 2013-07-09 | Human Biomolecular Research Institute | Synthesis of metabolically stable analgesics, pain medications and other agents |
AR053098A1 (es) * | 2004-11-04 | 2007-04-25 | Toray Industries | Analgesico derivado de morfinano |
CN101155814B (zh) | 2005-04-06 | 2010-06-16 | 东丽株式会社 | ***喃衍生物的晶体及其制备方法 |
ES2307352B1 (es) * | 2005-04-12 | 2009-09-18 | Bti, I+D, S.L. | Implante dental y piezas destinadas a ser conectadas a un implante dental, y la conexion interna entre el implante dental y cada pieza. |
AU2007240680B2 (en) | 2006-04-21 | 2013-05-02 | Nektar Therapeutics | Stereoselective reduction of a morphinone |
WO2008133297A1 (ja) | 2007-04-24 | 2008-11-06 | Toray Industries, Inc. | ジスキネジアの治療または予防剤 |
CN101686976B (zh) | 2007-04-26 | 2013-04-24 | 东丽株式会社 | 含有4,5-环氧基***喃衍生物的稳定的固体制剂 |
CA2691220C (en) | 2007-06-22 | 2015-05-05 | Toray Industries, Inc. | Remedy or preventive for integration dysfunction syndrome |
AU2008308005B2 (en) | 2007-10-05 | 2012-06-07 | Toray Industries, Inc. | Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient |
AU2009214500B2 (en) * | 2008-02-14 | 2014-10-23 | Alkermes, Inc. | Selective opioid compounds |
US8609682B2 (en) | 2008-07-11 | 2013-12-17 | Regents Of The University Of Minnesota | Analgesic agents |
CN102196811B (zh) | 2008-10-24 | 2014-03-19 | 东丽株式会社 | 含有4,5-环氧基***烷衍生物的稳定片剂 |
US8946419B2 (en) | 2009-02-23 | 2015-02-03 | Mallinckrodt Llc | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
CN102325776A (zh) * | 2009-02-23 | 2012-01-18 | 马林克罗特公司 | (+)-***喃*季盐及其制备方法 |
EP2398806A1 (en) * | 2009-02-23 | 2011-12-28 | Mallinckrodt LLC | (+)-morphinanium n-oxides and processes for their production |
CN102325775A (zh) * | 2009-02-23 | 2012-01-18 | 马林克罗特公司 | (+)-6-羟基-***喃或(+)-6-氨基-***喃衍生物 |
CA2764915C (en) * | 2009-06-11 | 2017-07-11 | Mallinckrodt Llc | Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer |
EP2440561B1 (en) * | 2009-06-11 | 2014-04-30 | Mallinckrodt LLC | Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer |
US8829020B2 (en) | 2009-07-16 | 2014-09-09 | Mallinckrodt Llc | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
US10363251B2 (en) | 2009-07-16 | 2019-07-30 | Mallinckrodt Llc | (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
US10131672B2 (en) | 2010-01-29 | 2018-11-20 | Toray Industries, Inc. | Therapeutic or prophylactic agent for biliary diseases |
WO2011154827A2 (en) | 2010-06-11 | 2011-12-15 | Rhodes Technologies | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
AU2011263416B2 (en) | 2010-06-11 | 2014-04-10 | Rhodes Technologies | Process for N-dealkylation of tertiary amines |
AU2010357625B2 (en) * | 2010-07-16 | 2015-04-23 | Mallinckrodt Llc | (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof |
AU2011317183B2 (en) * | 2010-10-19 | 2016-10-20 | Memorial Sloan-Kettering Cancer Center | 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |
CN103327977B (zh) | 2011-01-31 | 2016-05-04 | 东丽株式会社 | 恶液质的治疗或预防剂 |
PL2718294T3 (pl) | 2011-06-09 | 2019-04-30 | SpecGx LLC | Redukcyjne aminowanie 6-keto morfinanów przez katalityczne przeniesienie wodoru |
KR20140063763A (ko) | 2011-09-08 | 2014-05-27 | 말린크로트 엘엘씨 | 중간체를 단리하지 않는 알칼로이드의 제조 방법 |
EP2884978B1 (en) * | 2012-08-16 | 2019-07-17 | The Scripps Research Institute | Novel kappa opioid ligands |
TWI449704B (zh) * | 2013-04-26 | 2014-08-21 | Everlight Chem Ind Corp | 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物 |
US9969746B2 (en) | 2013-12-05 | 2018-05-15 | The University Of Bath | Opioid compounds and their uses |
JP2015166331A (ja) * | 2014-05-14 | 2015-09-24 | 遼東化学工業株式会社 | ナルフラフィンの結晶およびその製造方法 |
WO2016152953A1 (ja) * | 2015-03-24 | 2016-09-29 | 東レ株式会社 | モルヒナン誘導体及びその医薬用途 |
WO2016176657A1 (en) | 2015-04-30 | 2016-11-03 | Memorial Sloan-Kettering Cancer Center | Mitragynine analogs and uses thereof |
SG11201803191VA (en) | 2015-10-29 | 2018-05-30 | Univ Tsukuba | Morphinan derivative and medical usage thereof |
US11529340B2 (en) | 2016-03-22 | 2022-12-20 | Regents Of The University Of Minnesota | Combination for treating pain |
EP3458061B1 (en) * | 2016-05-19 | 2023-01-18 | Virginia Commonwealth University | Potent and selective mu opioid receptor modulators |
JP6814470B2 (ja) | 2017-02-10 | 2021-01-20 | 国立大学法人 筑波大学 | モルヒナン誘導体 |
WO2019168985A1 (en) * | 2018-02-27 | 2019-09-06 | Delpor, Inc. | Compositions for small molecule therapeutic agent compounds |
CA3091752A1 (en) | 2018-03-08 | 2019-09-12 | Victoria Link Ltd | Treatment of demyelinating diseases |
US11214577B2 (en) | 2019-03-29 | 2022-01-04 | Humanwell Pharmaceutical US | Morphinans useful for treating medical disorders |
US11613547B2 (en) * | 2019-07-08 | 2023-03-28 | University Of Health Sciences & Pharmacy In St. Louis | G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment |
AU2020360928A1 (en) | 2019-09-30 | 2022-04-14 | Nippon Chemiphar Co., Ltd. | Azepan derivative |
BR112022005457A2 (pt) | 2019-10-24 | 2022-06-21 | Toray Industries | Agente terapêutico ou profilático para caquexia |
CA3187797A1 (en) * | 2020-06-30 | 2022-01-06 | Toray Industries, Inc. | Ameliorating agent or prophylactic agent for muscle weakness symptom in disease or syndrome associated with metabolic disorder |
EP4327825A1 (en) | 2021-04-23 | 2024-02-28 | Toray Industries, Inc. | Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance |
CA3220039A1 (en) | 2021-06-14 | 2022-12-22 | Jr. David St. Jean | Urea derivatives which can be used to treat cancer |
WO2023190665A1 (ja) * | 2022-03-29 | 2023-10-05 | 東レ株式会社 | モルヒナン誘導体及びその医薬用途 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL290054A (no) * | ||||
US3236851A (en) * | 1966-02-22 | Unsaturated morphinan derivatives | ||
DE622231C (de) * | 1934-03-09 | 1935-11-23 | Hermann Fischer Dr | Verfahren zur Herstellung von Diacetylmorphin |
GB864107A (en) * | 1958-09-10 | 1961-03-29 | Albert Boehringer | Morphine derivatives |
GB919311A (en) * | 1958-10-29 | 1963-02-20 | T & H Smith Ltd | Derivatives of 14-hydroxycodeine and their preparation |
DE2254298A1 (de) * | 1972-11-06 | 1974-05-16 | Boehringer Sohn Ingelheim | Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel |
GB1587831A (en) * | 1977-03-23 | 1981-04-08 | Reckitt & Colmann Prod Ltd | Morphine derivatives |
GB1593191A (en) * | 1977-03-23 | 1981-07-15 | Reckitt & Colmann Prod Ltd | Derivatives of morphine |
US4362870A (en) * | 1980-01-16 | 1982-12-07 | Regents Of The University Of Minnesota | Selective opioid receptor alkylating agents |
JPS574991A (en) * | 1980-06-10 | 1982-01-11 | Sankyo Co Ltd | Cyclopropylmethylnormorphine-6-sulfuric ester |
US4401672A (en) | 1981-10-13 | 1983-08-30 | Regents Of The University Of Minnesota | Non-addictive narcotic antitussive preparation |
US4668685A (en) * | 1984-07-05 | 1987-05-26 | E.I. Du Pont De Nemours And Company | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists |
US4767718A (en) * | 1984-06-18 | 1988-08-30 | Southern Illinois University Foundation | Fluorescent opioid reagents and methods of use thereof in the detection of opioid receptors |
IN163125B (no) | 1985-01-08 | 1988-08-13 | Alkaloida Vegyeszeti Gyar | |
DE3617182A1 (de) | 1985-05-23 | 1986-11-27 | Sandoz-Patent-GmbH, 79539 Lörrach | Morphinan-derivate |
HU196376B (en) | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
US4730048A (en) | 1985-12-12 | 1988-03-08 | Regents Of The University Of Minnesota | Gut-selective opiates |
US4806556A (en) | 1985-12-12 | 1989-02-21 | Regents Of The University Of Minnesota | Gut-selective opiates |
US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
JPH01149788A (ja) * | 1987-12-08 | 1989-06-12 | Chugai Pharmaceut Co Ltd | 新規なモルヒネ誘導体 |
FR2636330B1 (fr) * | 1988-09-13 | 1990-11-30 | Sanofi Sa | Procede de preparation de derives de morphinane |
US5219861A (en) * | 1988-12-21 | 1993-06-15 | Chugai Seiyaku Kabushiki Kaisha | 6 β-Thiomorphine derivatives |
KR900009650A (ko) * | 1988-12-21 | 1990-07-05 | 사노하지메 | 신규 모르핀 유도체 |
US5258386A (en) * | 1991-06-05 | 1993-11-02 | The United States Of America As Represented By The Secretary Of The Army | (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents |
JP2525552B2 (ja) * | 1992-01-23 | 1996-08-21 | 東レ株式会社 | モルヒナン誘導体および医薬用途 |
AU683664B2 (en) * | 1993-06-30 | 1997-11-20 | Toray Industries, Inc. | Antitussive |
-
1993
- 1993-01-22 JP JP5509616A patent/JP2525552B2/ja not_active Expired - Lifetime
- 1993-01-22 CA CA002105072A patent/CA2105072C/en not_active Expired - Lifetime
- 1993-01-22 KR KR1019930702860A patent/KR970011390B1/ko not_active IP Right Cessation
- 1993-01-22 NZ NZ246687A patent/NZ246687A/en not_active IP Right Cessation
- 1993-01-22 DK DK93902520T patent/DK0577847T3/da active
- 1993-01-22 US US08/108,643 patent/US6323212B1/en not_active Expired - Lifetime
- 1993-01-22 ES ES93902520T patent/ES2121988T3/es not_active Expired - Lifetime
- 1993-01-22 EP EP98100805A patent/EP0846694A1/en not_active Withdrawn
- 1993-01-22 AU AU33671/93A patent/AU666702B2/en not_active Expired
- 1993-01-22 EP EP93902520A patent/EP0577847B1/en not_active Expired - Lifetime
- 1993-01-22 WO PCT/JP1993/000080 patent/WO1993015081A1/ja active IP Right Grant
- 1993-01-22 AT AT93902520T patent/ATE172201T1/de active
- 1993-01-22 DE DE69321525T patent/DE69321525T2/de not_active Expired - Lifetime
- 1993-01-30 TW TW082100590A patent/TW332814B/zh not_active IP Right Cessation
- 1993-09-22 FI FI934144A patent/FI106126B/fi not_active IP Right Cessation
- 1993-09-22 NO NO933376A patent/NO302755B1/no not_active IP Right Cessation
-
1995
- 1995-12-22 AU AU40671/95A patent/AU686483B2/en not_active Expired
-
2000
- 2000-03-31 US US09/541,793 patent/US6277859B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR970011390B1 (ko) | 1997-07-10 |
FI934144A0 (fi) | 1993-09-22 |
EP0577847A1 (en) | 1994-01-12 |
AU3367193A (en) | 1993-09-01 |
DE69321525T2 (de) | 1999-03-04 |
AU4067195A (en) | 1996-03-07 |
ES2121988T3 (es) | 1998-12-16 |
TW332814B (en) | 1998-06-01 |
CA2105072A1 (en) | 1993-07-24 |
EP0577847A4 (en) | 1994-12-07 |
NO933376L (no) | 1993-09-23 |
DK0577847T3 (da) | 1999-06-23 |
NO933376D0 (no) | 1993-09-22 |
CA2105072C (en) | 1998-07-28 |
US6277859B1 (en) | 2001-08-21 |
JPH08502275A (ja) | 1996-03-12 |
NZ246687A (en) | 1996-12-20 |
AU686483B2 (en) | 1998-02-05 |
FI934144A (fi) | 1993-09-22 |
US6323212B1 (en) | 2001-11-27 |
ATE172201T1 (de) | 1998-10-15 |
FI106126B (fi) | 2000-11-30 |
DE69321525D1 (de) | 1998-11-19 |
JP2525552B2 (ja) | 1996-08-21 |
EP0846694A1 (en) | 1998-06-10 |
AU666702B2 (en) | 1996-02-22 |
WO1993015081A1 (fr) | 1993-08-05 |
EP0577847B1 (en) | 1998-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO302755B1 (no) | Morfinan-derivater | |
KR960702464A (ko) | Dc-89 유도체[dc-89 derivative] | |
DK0423714T3 (da) | Hårrevitaliseringsmiddel | |
ATE139778T1 (de) | Xanthinverbindungen | |
DK232989D0 (da) | Antiviralt praeparat | |
YU46998B (sh) | Postupak za dobijanje derivata cefema i medjuproizvoda za iste | |
ATE172463T1 (de) | Pyrrolocarbazol | |
KR950701615A (ko) | 혈소판 응집 저해작용을 갖는 신규한 화합물(novel compound with plate-let aggregation inhibitor activity) | |
DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
FI904449A0 (fi) | N-azasicyklo/3.3.0/oktanamider av aromatiska syror. | |
JPS56131571A (en) | Novel hetero ring substituted carboxyamide and methyl amine compound | |
ATE159525T1 (de) | Kondensierte naphthyridinderivate | |
ES2149180T3 (es) | Derivado de pirazolotiazolopirimidina. | |
DE69314573D1 (de) | 2-Thiazolylpyrroleakrylate mit fungizider Wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |